论文部分内容阅读
评价老年人急性脑梗塞尿激酶静脉溶栓治疗的有效性和安全性。方法分析２６例急性脑梗塞病人静脉溶栓治疗的临床资料，以６０岁为界分为老年组和青中年组进行比较。结果①老年组和青中年组均有良好的疗效，有效率依次分别为６２．５％和７０．０％；②出血合并症在老年组较多，但多数为轻微皮肤出血；③溶栓后再梗塞的机会老年组较多。结论用尿激酶静脉溶栓治疗老年人急性脑梗塞与青中年患者相比同样有效，也比较安全，但溶栓后再梗塞的机会较多。
To evaluate the efficacy and safety of intravenous thrombolysis in the elderly with acute cerebral infarction. Methods The clinical data of 26 patients with acute cerebral infarction treated by intravenous thrombolysis were analyzed. The age of 60 years was divided into the elderly group and the young middle age group for comparison. Results ① The elderly group and the middle-aged group had good curative effect, the effective rates were 62.5% and 70.0% respectively; ② The hemorrhagic complications were more in the elderly group, but the majority were mild skin hemorrhage; ③ Thrombolysis Elderly group after more chance of infarction. Conclusion Intravenous thrombolysis with urokinase in elderly patients with acute cerebral infarction compared with young middle-aged patients as effective, but also more secure, but more chance of infarction after thrombolysis.